Disruption of sphingolipid metabolism promotes tau seeding through endolysosomal membrane rigidification and rupture
Jessica TittelmeieriD, Carl Alexander SandhofiD, Nicole MartiniD, Deike El-Kabarity, Soki-Bradel Ngonza-Nito, Ronald MelkiiD, Carmen I. Nussbaum-KrammeriD
Abstract
Endolysosomal dysfunction is a hallmark of Alzheimers disease (AD) and related tauopathies, yet underlying mechanisms remain poorly understood. This study investigates the role of sphingolipid metabolism in maintaining endolysosomal membrane integrity and its impact on tau aggregation and toxicity in Caenorhabditis elegans and human cell culture models. Fluorescence recovery after photobleaching and C-Laurdan dye imaging revealed that silencing sphingolipid metabolism genes reduced endolysosomal vesicle membrane fluidity, increasing their rupture. The accumulation of aggregated tau in endolysosomal vesicles further aggravated endomembrane rigidification and damage and promoted seeded tau aggregation, potentially by facilitating the escape of tau seeds from the endolysosomal system. Supplementation with unsaturated fatty acids improved membrane fluidity, suppressing endolysosomal rupture and seeded tau aggregation in cell models, and alleviating tau-associated neurotoxicity in C. elegans. Together, this study provides mechanistic insight into how perturbation of sphingolipid metabolism promotes endolysosomal membrane damage and contributes to the escape of aggregated tau from this compartment, suggesting that restoration of membrane fluidity may represent a strategy to limit tau propagation and toxicity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Novel C. elegans Model for Tau spreading Reveals Genes Critical for Endolysosomal Integrity and Seeded Tau Aggregation
Carl Alexander Sandhof, Nicole Martin, … Carmen I. Nussbaum-Krammer·AutophagyPeer-reviewed·Aug 25, 2025
- Lipid flippase dysfunction as a novel therapeutic target for endosomal anomalies in Alzheimer's disease
N. KANESHIRO, K. MASATO, … N. TAKASUGI·bioRxiv·Jul 30, 2021
- Compromised function of the ESCRT pathway promotes endolysosomal escape of tau seeds and propagation of tau aggregation
J. J. Chen, D. L. Nathaniel, … M. Kampmann·bioRxiv·Sep 26, 2019
- Tau fibrils induce nanoscale membrane damage and nucleate cytosolic tau at lysosomes
K. Rose, T. Jepson, … J. H. Hurley·Proceedings of the National Academy of SciencesPeer-reviewed·May 23, 2024
- Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies.
Dominika Olešová, Dana Dobešová, … Andrej Kováč·Journal of NeuroinflammationPeer-reviewed·Mar 27, 2024
- Dihydrolipoamide dehydrogenase suppression induce human tau phosphorylation by increasing whole body glucose levels in a C. elegans model of Alzheimer’s Disease
Waqar Ahmad·Experimental Brain ResearchPeer-reviewed·Jul 28, 2018